Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger

Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations

(2010) M. E. Sherman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Use of Four Biomarkers to Evaluate the Risk of Breast Cancer Subtypes in the Women's Contraceptive and Reproductive Experiences Study

(2010) H. Ma et al.   CANCER RESEARCH

Emerging Technologies for Assessing HER2 Amplification

(2009) Frédérique Penault-Llorca et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Is There a Difference in the Association between Percent Mammographic Density and Subtypes of Breast Cancer? Luminal A and Triple-Negative Breast Cancer

(2009) H. Ma et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years

(2009) J. M. Dolle et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Obesity and Breast Cancer: The Estrogen Connection

(2009) Margot P. Cleary et al.   ENDOCRINOLOGY

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

(2008) Mary Jo Lund et al.   BREAST CANCER RESEARCH AND TREATMENT

Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer

(2008) Amanda I. Phipps et al.   CANCER

Body Size and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer in Postmenopausal Women

(2008) A. I. Phipps et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Recent Trends in Breast Cancer Among Younger Women in the United States

(2008) Louise A. Brinton et al.   JNCI-Journal of the National Cancer Institute

Obesity and cancer: Pathophysiological and biological mechanisms

(2008) Andrew G. Renehan et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY